About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

2017 Annual Report

March 28, 2018

Click here to read more

Post navigation

Notification of AGM Date

Investor Presentation April 2018

Related Posts

Retirement of Non-Executive Director

May 28, 2018

Avecho commences CBD softgel manufacturing for pivotal Phase III insomnia study

May 17, 2023May 17, 2023

Avecho and Sandoz enter exclusive license and development agreement to commercialise CBD for insomnia in Australia

March 3, 2025March 3, 2025

Recent Posts

Recruitent recommences for phase III insomnia trial
August 31, 2026
Euroz Hartleys | Successful Phase 3 Interim Results
July 8, 2026
Avecho Phase III insomnia trial advances following positive interim analysis
June 24, 2026

Categories

Analyst Coverage
Company Announcement
Company Report
Investor Webinar
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.